Arvinas and Pfizer complete Rigel license deal for vepdegestrant
Go back to Arvinas and Pfizer complete Rigel license deal for vepdegestrant| (NASDAQ: ARVN) | Delayed: 8.71 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.71 | 52 Week High | $ | |||
| Open | $8.71 | 52 Week Low | $ | |||
| Day High | $8.71 | P/E | N/A | |||
| Day Low | $8.71 | EPS | $ | |||
| Volume | 207 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 27.65 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.65 | 52 Week High | $37.39 | |||
| Open | $27.65 | 52 Week Low | $28.25 | |||
| Day High | $27.65 | P/E | 16.76 | |||
| Day Low | $27.65 | EPS | $1.65 | |||
| Volume | 32,376 | |||||
